Sars-CoV-2 in pregnancy: Why is it better than expected?


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 27 06 2020
revised: 09 07 2020
accepted: 11 07 2020
pubmed: 3 8 2020
medline: 12 9 2020
entrez: 3 8 2020
Statut: ppublish

Résumé

Since the outbreak of Coronavirus disease in December 2019, information specific to pregnancy remains limited and controversial. Based on data from previous reports, it has been noticed that contrary to prior pandemics such as SARS, MERS and H1N1 and although pregnancy is usually considered as a condition of high susceptibility to viral infections, new SARS-CoV2 infection seems to have a more benign clinical course when affecting pregnant women. We speculate that during pregnancy the physiological "silencing" of the Th1 pro-inflammatory response may blunt the cytokines storm which is thought to play a key-role in the pathogenesis of the severe complications of Covid-19.

Identifiants

pubmed: 32739606
pii: S0301-2115(20)30467-X
doi: 10.1016/j.ejogrb.2020.07.025
pmc: PMC7378463
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

476-478

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None to declare

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
Best Pract Res Clin Obstet Gynaecol. 2013 Dec;27(6):791-802
pubmed: 24012425
Infez Med. 2020 Jun 1;28(suppl 1):46-51
pubmed: 32532938
Front Immunol. 2020 Jan 14;10:3100
pubmed: 31993063
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Travel Med Infect Dis. 2020 Apr 11;:101665
pubmed: 32283217
BMJ. 2020 Mar 24;368:m1201
pubmed: 32209544
J Perinat Med. 2020 Jun 25;48(5):428-434
pubmed: 32452195
Sci Immunol. 2017 Sep 1;2(15):
pubmed: 28864494
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279
JAMA. 2010 Apr 21;303(15):1517-25
pubmed: 20407061
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:605-609
pubmed: 32620513
Int J Womens Health. 2014 Jul 25;6:681-9
pubmed: 25114593

Auteurs

Tullio Ghi (T)

Department of Obstetrics and Gynecology, University of Parma, Parma, Italy. Electronic address: tullio.ghi@unipr.it.

Elvira di Pasquo (E)

Department of Obstetrics and Gynecology, University of Parma, Parma, Italy.

Arsene Mekinian (A)

Department of Internal Medicine, Referral Center for Autoimmune Diseases, Saint Antoine Hospital, Sorbonne University, Paris, France.

Leonardo Calza (L)

Unit of Infectious Diseases, Department of Medical and Surgical Sciences, S. Orsola Hospital, "Alma Mater Studiorum" University of Bologna, Bologna, Italy.

Tiziana Frusca (T)

Department of Obstetrics and Gynecology, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH